Institute for Pharmacy
Clinical Pharmacy
In 2017, Paracelsus Medical Private University (PMU) became one of the first institutions in Austria to establish a professorship in clinical pharmacy. Clinical Pharmacy is a branch of pharmacy that focuses on the application of medications in clinical practice, directly involving patient care.
It emphasizes collaboration between pharmacists and other healthcare providers, particularly doctors and nurses. The goal of clinical pharmacy is to ensure the best possible medication therapy for individual patients.
Our research focuses on developing innovative and digital approaches to optimize patient-centered pharmacotherapy, as well as the implementation and evaluation of pharmaceutical services within healthcare and patient care systems.
Research areas
The field of pharmacotherapy and translational research focuses on the use of medications. While the quality of therapy is influenced by drug safety, it is also important that the therapeutic goals are achieved. Pharmacotherapy always involves patients. PMU is one of the few universities in the German-speaking world that emphasizes pharmacotherapy in both research and teaching. We have brought this concept to life, and the idea for the successful pharmacotherapy textbook originated from our research group.
Therapy optimization
Research in pharmacotherapy can sometimes provide as much benefit as drug development itself. Through clinical research, new uses for existing drugs can be discovered. We conduct projects that address unresolved clinical questions. For example:
- What is the best treatment strategy for a specific condition?
- Is it safe to switch between generic medications?
- Can established drugs be repurposed for new indications?
Medication management
A key focus of pharmacotherapy research at the PMU is medication management. We combine efficacy studies with digitalization efforts, creating a unique expertise. We contribute to classifications, set standards, and conduct medication reviews in various settings. Several studies on patient selection have been carried out. We developed decision-support software that is in regular use.
Examples include:
- WestGEM Study on medication management
- AMBER Study on medication management
- mediPORT Patient Selection Study
- EMMA Study on patient perspectives
- Standards in Medication Management
- PCNE drug-related problem classification
Digitalization and AI
Digitalization simplifies decision-making and offers new opportunities for pharmacotherapy research. In addition to algorithms for medication management and patient selection, artificial intelligence (AI) provides a chance to improve therapy quality. We are exploring the possibilities and limitations of decision-support software.
Examples include:
- Development of QMR software for medication management
- Patient selection calculator
- Testing AI for therapy optimization
Parkinson's disease
Parkinson’s disease has been a key focus of our research for many years. We explore Levodopa formulations, disease progression, and networked approaches, all aimed at enhancing the quality of life for patients.
Examples include:
- Pharmaceutical aspects in Parkinson’s networks
- Managing complications, such as Parkinson’s psychosis
Pharmaceutical practice and care
Pharmacies play a crucial role in healthcare systems, yet much of their potential remains untapped. To maximize their impact on society, the transition from logistics to offering services and therapies must be supported by research.
Examples include:
- Introduction of vaccinations in pharmacies
- Conducting screenings and measurements
- Medication management
- Interaction management
- Assisted dying
- Managing supply shortages
- Ensuring the quality of SARS-CoV-2 testing in pharmacies
Translational research
From bench to bedside, we ensure our findings are directly accessible by pharmacists.
Examples include:
- POP cases published in the German Pharmacist Journal
- Pharmacotherapy textbook
- Contributions to national guidelines on hypertension and coronary heart disease
- Regular presentations at conferences and publications in professional journals